Singapore HSA registration DE0504106
BD BBL™ Sorbitol MacConkey II Agar with Cefixime and Tellurite
Singapore·CLASS B IVD·Becton, Dickinson and Company·Registered February 11, 2020Device classification
- Device Class
- CLASS B IVD
- Medical Speciality Area
- Microbiology
Registration information
- Registration Number
- DE0504106
- Registration Date
- February 11, 2020
- Retention Due Date
- February 10, 2026
Product description
BD BBL™ Sorbitol MacConkey II Agar with Cefixime and Tellurite is used as a selective and differential medium for the detection of Escherichia coli serotype O157:H7.
Product Owner
- Short Name
- Becton, Dickinson and Company
- Address
- 7 Loveton Circle, Sparks, Maryland, 21152, UNITED STATES
Registrant
- Address
- 10 COLLYER QUAY, OCEAN FINANCIAL CENTRE, #10-01, SINGAPORE 049315
Importer
- Address
- 10 COLLYER QUAY, OCEAN FINANCIAL CENTRE, #10-01, SINGAPORE 049315
Model information
- Model Name(s)
- BD BBL™ Sorbitol MacConkey II Agar with Cefixime and Tellurite
- Model Identifier(s)
- 222226
About this record
Access comprehensive regulatory information for BD BBL™ Sorbitol MacConkey II Agar with Cefixime and Tellurite in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0504106 and owned by Becton, Dickinson and Company. The device was registered on February 11, 2020.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Free DatabasePowered by Pure Global AIHSA Official DataCLASS B IVD